Cardioversion for Atrial Fibrillation: Does Inflammation Matter?

American Journal of Cardiology

Volumn 99, Issue 11, 2007, Pages 1617-1618

  Watson, Timothy ^a   Kakar, Puneet ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ARTICLE; CARDIOVASCULAR INFLAMMATION; CARDIOVASCULAR RISK; CARDIOVERSION; COMORBIDITY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HEART ATRIUM CONDUCTION; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; INFLAMMATORY INFILTRATE; MAINTENANCE THERAPY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; SINUS RHYTHM;

EID: 34248680752     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.12.089     Document Type: Note

References (27)

1. Crijns H.J., Van Gelder I.C., Van der Woude H.J., Grandjean J.G., Tieleman R.G., Brugemann J., De Kam P.J., and Ebels T. Efficacy of serial electrical cardioversion therapy in patients with chronic atrial fibrillation after valve replacement and implications for surgery to cure atrial fibrillation. Am J Cardiol 78 (1996) 1140-1144
2. Bertaglia E., D'Este D., Zerbo F., Zoppo F., Delise P., and Pascotto P. Success of serial external electrical cardioversion of persistent atrial fibrillation in maintaining rhythm; a randomized study. Eur Heart J 23 (2002) 1522-1528
3. Haissaguerre M., Jais P., Shah D.C., Takahashi A., Hocini M., Quiniou G., Garrigue S., Le Mouroux A., Le Metayer P., and Clementy J. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 339 (1998) 659-666
4. Hindricks G., Piorkowski C., Tanner H., Kobza R., Gerds-Li J.H., Carbucicchio C., and Kottkamp H. Perception of atrial fibrillation before and after radiofrequency catheter ablation: relevance of asymptomatic arrhythmia recurrence. Circulation 112 (2005) 307-313
5. Karch M.R., Zrenner B., Deisenhofer I., Schreieck J., Ndrepepa G., Dong J., Lamprecht K., Barthel P., Luciani E., Schomig A., and Schmitt C. Freedom from atrial tachyarrhythmias after catheter ablation of atrial fibrillation: a randomized comparison between 2 current ablation strategies. Circulation 111 (2005) 2875-2880
6. Wijffels M.C., Kirchhof C.J., Dorland R., Power J., and Allessie M.A. Electrical remodeling due to atrial fibrillation in chronically instrumented conscious goats: roles of neurohumoral changes, ischemia, atrial stretch, and high rate of electrical activation. Circulation 96 (1997) 3710-3720
7. Boldt A., Wetzel U., Lauschke J., Weigl J., Gummert J., Hindricks G., Kottkamp H., and Dhein S. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 90 (2004) 400-405
8. Hertervig E.J., Yuan S., Carlson J., Kongstad-Rasmussen O., and Olsson S.B. Evidence for electrical remodelling of the atrial myocardium in patients with atrial fibrillation. A study using the monophasic action potential recording technique. Clin Physiol Funct Imaging 22 (2002) 8-12
9. Spach M.S., and Dolber P.C. Relating extracellular potentials and their derivatives to anisotropic propagation at a microscopic level in human cardiac muscle. Evidence for electrical uncoupling of side-to-side fiber connections with increasing age. Circ Res 58 (1986) 356-371
10. Boos C.J., Anderson R.A., and Lip G.Y. Is atrial fibrillation an inflammatory disorder?. Eur Heart J 27 (2006) 136-149
11. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., and Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 104 (2001) 174-180
12. Frustaci A., Chimenti C., Bellocci F., Morgante E., Russo M.A., and Maseri A. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation 96 (1997) 1180-1184
13. Venugopal S.K., Devaraj S., and Jialal I. Effect of C-reactive protein on vascular cells: evidence for a proinflammatory, proatherogenic role. Curr Opin Nephrol Hypertens 14 (2005) 33-37
14. Szmitko P.E., Wang C.H., Weisel R.D., de Almeida J.R., Anderson T.J., and Verma S. New markers of inflammation and endothelial cell activation, part I. Circulation 108 (2003) 1917-1923
15. Rost N.S., Wolf P.A., Kase C.S., Kelly-Hayes M., Silbershatz H., Massaro J.M., D'Agostino R.B., Franzblau C., and Wilson P.W. Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: the Framingham study. Stroke 32 (2001) 2575-2579
16. Sata N., Hamada N., Horinouchi T., Amitani S., Yamashita T., Moriyama Y., and Miyahara K. C-reactive protein and atrial fibrillation. Is inflammation a consequence or a cause of atrial fibrillation?. Jpn Heart J 45 (2004) 441-445
17. Chung M.K., Martin D.O., Sprecher D., Wazni O., Kanderian A., Carnes C.A., Bauer J.A., Tchou P.J., Niebauer M.J., Natale A., and Van Wagoner D.R. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation 104 (2001) 2886-2891
18. Watanabe T., Takeishi Y., Hirono O., Itoh M., Matsui M., Nakamura K., Tamada Y., and Kubota I. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation. Heart Vessels 20 (2005) 45-49
19. Roldan V., Marin F., Blann A.D., Garcia A., Marco P., Sogorb F., and Lip G.Y. Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation. Eur Heart J 24 (2003) 1373-1380
20. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Relationship of interleukin-6 and C-reactive protein to the prothrombotic state in chronic atrial fibrillation. J Am Coll Cardiol 43 (2004) 2075-2082
21. Conway D.S., Buggins P., Hughes E., and Lip G.Y. Prognostic significance of raised plasma levels of interleukin-6 and C-reactive protein in atrial fibrillation. Am Heart J 148 (2004) 462-466
22. Lip G.Y., Patel J.V., Hughes E., and Hart R.G. High sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema and prognosis. Stroke 38 (2007) 1229-1237
23. Das U.N. Is angiotensin-II an endogenous pro-inflammatory molecule?. Med Sci Monit 11 (2005) 155-162
24. Suzuki Y., Ruiz-Ortega M., Lorenzo O., Ruperez M., Esteban V., and Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 35 (2003) 881-900
25. Ohmichi N., Iwai N., Shimoike H., Izumi M., Watarida S., Mori A., Nakamura Y., and Kinoshita M. Assessment of the angiotensin II-forming pathway in human atria. Heart Vessels suppl (1997) 116-118
26. Goette A., Staack T., Rocken C., Arndt M., Geller J.C., Huth C., Ansorge S., Klein H.U., and Lendeckel U. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 35 (2000) 1669-1677
27. Tveit A., Seljeflot I., Grundvold I., Abdelnoor M., Smith P., and Arnesen H. Effect of candesartan and various inflammatory markers on maintenance of sinus rhythm after electrical cardioversion for atrial fibrillation. Am J Cardiol 99 (2007) 1544-1548